tldrdaily.news logo
Tag

Buprenorphine

All articles tagged with #buprenorphine

health1 year ago

"New Initiatives and Medications Show Promise in Addressing Opioid Overdoses and Addiction"

Fire Capt. Jesse Blaire, a paramedic in Ocala, Florida, is leading a program to combat the opioid crisis by delivering addiction medication, such as buprenorphine, directly to patients' homes. This initiative aims to provide comprehensive support to individuals struggling with opioid addiction, addressing withdrawal symptoms and connecting them with recovery services. Blaire's efforts have resulted in significant positive outcomes, including helping individuals stabilize and access treatment programs, demonstrating the potential impact of meeting people where they are in addressing the opioid epidemic.

via CNN|
#addiction-medication#buprenorphine#health
health-addiction-treatment1 year ago

"U.S. Opioid Crisis: Methadone and Buprenorphine Sidelines"

The U.S. is failing to effectively utilize medications like methadone and buprenorphine to prevent opioid overdose deaths, with various sectors obstructing their use. Despite their proven effectiveness in reducing overdose deaths and helping individuals achieve stable, healthy lives, barriers such as limited access, stigma, and opposition from organizations like Narcotics Anonymous and methadone clinics persist. The prevailing attitude in the U.S. often favors ineffective detox and 12-step approaches over medication-assisted treatment, contributing to the opioid crisis and exacerbating racial health disparities. Efforts to expand access to these medications and shift attitudes are underway, but outdated laws and practices continue to impede progress.

via STAT|
#addiction-treatment#buprenorphine#health-addiction-treatment
health1 year ago

"Rising Child Drug Overdose Deaths: How Can Pediatricians Intervene?"

Pediatricians like Dr. Safdar Medina are treating adolescents with opioid addiction using medications like buprenorphine, but only 6% of pediatricians offer this treatment despite a rise in overdose deaths among 10-19-year-olds. The lack of training and resources, along with the prevalence of counterfeit pills laced with fentanyl, complicates efforts to combat overdoses. Experts suggest pediatricians should screen for drug use, prescribe naloxone, and engage in conversations about substance abuse. Despite concerns about side effects, buprenorphine is seen as a critical tool in saving young lives from opioid overdose.

via NPR|
#adolescent-medicine#buprenorphine#drug-overdose
health2 years ago

"Portland Fire & Rescue Initiates Opioid Addiction Treatment Distribution Program"

Portland Fire & Rescue is launching a pilot program to distribute medication, such as buprenorphine, to treat opioid use disorder at the time of 9-1-1 responses, aiming to reduce overdose deaths and provide lasting recovery for community members. The program, funded by a $400,000 grant from CareOregon, will enroll patients immediately and track their progress, complementing a recent initiative to send smaller vehicles to respond to overdoses.

via Willamette Week|
#buprenorphine#health#opioid-addiction-treatment
health2 years ago

Rethinking Buprenorphine Treatment in the Fentanyl Crisis

A study conducted in Rhode Island suggests that individuals with opioid use disorder may require higher doses of the medication buprenorphine to improve treatment retention, particularly in the face of the fentanyl crisis. The study found that patients prescribed a daily dose of 24 milligrams (mg) of buprenorphine were 20% more likely to remain in treatment compared to those prescribed the recommended 16 mg dose. The findings highlight the need to re-evaluate dosing guidelines for buprenorphine in order to optimize treatment and help individuals with opioid use disorder achieve recovery.

via PsyPost|
#buprenorphine#dose-adjustment#fentanyl-crisis
health2 years ago

Optimal buprenorphine doses enhance treatment retention for opioid use disorder

A study funded by the National Institute on Drug Abuse (NIDA) suggests that higher doses of buprenorphine may improve retention in treatment for opioid use disorder. The study, conducted in Rhode Island from 2016 to 2020, found that individuals prescribed a lower dose of buprenorphine were 20% more likely to discontinue treatment compared to those on a higher dose. The findings highlight the need to reevaluate clinical guidelines for opioid addiction treatment, particularly in the context of the fentanyl crisis. The study supports the growing evidence that higher doses of buprenorphine are safe and effective in reducing opioid use and improving treatment outcomes.

via National Institutes of Health (.gov)|
#buprenorphine#clinical-guidelines#fentanyl-crisis
health2 years ago

Lack of Access to Medication for Teen Opioid Addiction Treatment

Only 1 in 4 residential addiction treatment programs for teenagers provide buprenorphine, the most effective medication for opioid use disorder, according to a study. The research team identified 354 facilities nationwide and found that just 39 facilities, or 24%, said they offered buprenorphine as part of their treatment plan. Some facilities had never heard of the drug. Equine therapy was more commonly offered than buprenorphine in the surveyed facilities, despite limited research that working with horses can actually treat opioid use disorder.

via NBC News|
#buprenorphine#health#opioid-addiction
health2 years ago

Lack of Access to Addiction Medication for Teenagers in the US

Only 1 in 4 residential treatment centers for teens offers buprenorphine, a recommended medicine for opioid addiction, according to a study. Of 160 facilities with care for teens, just 39 provided buprenorphine, also known by the brand name Suboxone. Despite guidelines recommending medication and evidence it prevents overdose deaths, buprenorphine and other treatment drugs aren’t universally accepted. Some believe they replace one drug with another and that abstinence is the best recovery path.

via The Associated Press|
#addiction-treatment#buprenorphine#health
health2 years ago

FDA Approves Multiple New Options for Opioid Use Disorder Treatment and Overdose Reversal

The FDA has approved Brixadi, a new buprenorphine extended-release injection for subcutaneous use, to treat moderate to severe opioid use disorder. Brixadi is available in weekly and monthly formulations and offers a new option for people in recovery who may benefit from a weekly injection to maintain treatment adherence. The most common adverse reactions include injection-site pain, headache, constipation, nausea, injection-site erythema, itchy skin at the injection site, insomnia, and urinary tract infections. The FDA continues to implement a comprehensive approach to increase options to treat OUD.

via FDA.gov|
#buprenorphine#fda#health
health2 years ago

The Struggle to Access Opioid Craving Medication.

Racial disparities in access to buprenorphine, a medication used to treat opioid addiction, persist, according to a new study from the Harvard T.H. Chan School of Public Health. The study found that White patients are up to 80% more likely to receive buprenorphine than Black patients, and that Black patients receive a more limited supply. Experts say there are many reasons for the disparities in buprenorphine access, including a lack of providers willing to prescribe the medication, bias in prescribing, distrust of medical institutions, and racism long ingrained in the U.S. health system.

via The Washington Post|
#buprenorphine#health#medicare
health2 years ago

Medicare report shows low misuse of buprenorphine as opioid substitute.

A government oversight report has found that less than 1% of Medicare recipients misused buprenorphine, a drug used to treat opioid addiction and stem overdose deaths. Despite concerns that the drug would be abused, the report concluded that buprenorphine is "critical to addressing the nation's opioid crisis" but likely isn't prescribed enough. The report urged the Centers for Medicare and Medicaid Services to use all tools at their disposal to address the crisis and make buprenorphine available to people with opioid-use disorder.

via USA TODAY|
#buprenorphine#drug-misuse#health
health2 years ago

Racial Disparities in Access to Opioid Addiction Treatment Medication

A new study has found that the most effective treatments for opioid addiction are vastly underprescribed in the US, especially for Black patients. From 2016 to 2019, only 20% of patients diagnosed with opioid use disorder filled prescriptions for buprenorphine, the medication considered the gold standard in opioid addiction treatment. Within six months following a high-risk event like an overdose, white patients filled buprenorphine prescriptions up to 80% more often than Black patients, and up to 25% more often than Latino patients. Rates of use for methadone, another effective treatment, were generally even lower. The study suggests that racial differences in patient trust and demand for buprenorphine, as well as where people of color get their healthcare, could explain the disparities.

via The New York Times|
#addiction-treatment#buprenorphine#health
health2 years ago

Telehealth and Buprenorphine: Effective Tools in Reducing Opioid Overdose Deaths

A multi-site clinical trial supported by the National Institutes of Health showed that less than 1% of people with opioid use disorder whose drug use includes fentanyl experienced withdrawal when starting buprenorphine in the emergency department. The findings are strong evidence that buprenorphine can be safely started in the emergency department without triggering withdrawal, even for people who use stronger opioids. The study addressed the question of how the prevalence of fentanyl in the drug supply affects the process of addiction treatment for people with opioid use disorder.

via National Institutes of Health (.gov)|
#addiction-treatment#buprenorphine#emergency-department